December 08, 2016 by Stewart Eisenhart EMERGO SUMMARY OF KEY POINTS: New legislation significantly impacting FDA oversight of US medical device and drug markets has passed Congress and is awaiting President Obama’s signature. The 21st Century Cures Act would establish a priority review program for breakthrough devices, loosen some device clinical trial requirements and clarify […]